资讯 | 科创板今日开板。联储降息前景备受关注,美股周五收跌。

wechat omage

美股

北京时间7月19日凌晨,美股周五收跌。标普500指数与纳指录得5月底以来的最大单周跌幅。财报与美联储的政策前景备受关注。分析师认为美联储在7月底更有可能降息25个基点,而不是市场期待的50个基点。

截止收盘,道指跌68.77点,或0.25%,报27154.20点;标普500指数跌18.50点,或0.62%,报2976.61点;纳指跌60.75点,或0.74%,报8146.49点。

美国运通(AXP)领跌道指,此前该公司公布的业绩展望令人失望。

本周标普500指数与纳指均下跌超过1%,为5月底以来的最大单周跌幅。道指本周下跌0.6%。

美联储试图淡化纽约联储行长约翰-威廉姆斯(John Williams)周四鸽派讲话的影响。威廉姆斯周四的讲话被市场解读为全面倒向鸽派,导致联邦基金基准利率市场预测联邦公开市场委员会(FOMC)更有可能在7月30-31日会议上采取非同寻常的降息50个基点措施。目前美联储的联邦基金基准利率区间是2.25%至2.5%。

威廉姆斯在周四的一个学术研究会议上表示:“当你只有这么多的刺激措施时,在经济困境的迹象首次出现时就迅速采取措施降低利率是值得的。”

不过纽约联储发言人随后表示,威廉姆斯的讲话仅仅是学术性的,并不是对未来政策的预测。纽约联储发言人称“这是基于20年研究成果的学术演讲,与即将召开的FOMC会议的潜在政策行动无关。”

一些市场参与者认为,美联储发声消除纽约联邦储备银行评论影响的行为很反常。CMC Markets首席市场分析师Michael Hewson在周五的研究报告中表示:“纽约联储银行官员采取的这一举措不同寻常,表明他们担心市场对于月底降息50个基点的预期有些过高。”

分析师认为,纽约联储认为有必要澄清威廉姆斯的言论,表明威廉姆斯有关货币政策的观点不是美联储的主流观点。分析师称:“美联储的主流可能支持降息25个基点,然后观望。他们不会降息50基点,鉴于美国的经济背景,他们没有必要这样做。”

根据芝加哥商业交易所集团(CME Group)的数据,联邦基金期货显示:美联储在月底会议上降息半个百分点的可能性仍高达46%,降息25个基点的可能性为54%。

美国总统特朗普周五再次发声批评美联储,他在推特上抱怨说美国支付的“利率远高于其他国家”,还说威廉姆斯的第一份声明比第二份好多了。

投资者同时还在关注一些重量级公司的财报表现。微软(MSFT)周四晚间公布的盈利超出预期,因其Azure云业务及LinkedIn盈利强劲增长。

中东紧张局势亦受关注。美国总统特朗普周四表示,一艘美国海军舰艇在霍尔木兹海峡的“防御行动”中摧毁了一架伊朗无人机。但伊朗称没有无人机被击落。

伊朗副外长阿拉格齐19日上午在其社交网媒体上表示,伊朗没有发现在霍尔木兹海峡或是任何地方有无人机损失的情况发生。他进一步称怀疑是美军误打下了自己的无人机。

周五,伊朗据称在阿曼湾扣留了一艘悬挂英国船旗的油轮,令市场担心中东紧张局势进一步恶化、原油供应可能受到影响。

焦点股关注:

航空与国防承包行业巨头波音(BA)宣布,将在第二财季内承担与波音737 Max停飞相关的49亿美元开支。波音收高4.5%。投资管理与咨询顾问公司贝莱德(BLK)宣布第二财季盈利与营收均低于市场预期,并表示其证券、贷款营收下降,导致基础业务营收降低。该股收跌0.4%。美国运通(AXP)第二季度营收为108亿美元,市场预期为108.24亿美元,去年同期为100.02亿美元;第二季度净利润为17.61亿美元,市场预期为16.92亿美元,去年同期为16.23亿美元。美国运通收跌2.8%。

 

   

港股

北京时间7月19日,美股周四收高。投资者正在评估美企财报、国际贸易关系的进展及美联储的货币政策前景。韩国、印尼及南非央行相继宣布降息,显示全球央行降息潮或已开启。纽约联储行长称,美联储最明智的策略就是在经济疲软迹象刚一出现时就立即降息。周五开盘,港股恒指高开0.43%,随后涨幅扩大至1%

截至收盘,恒生指数涨1.07%,报28765.40点;国企指数涨1.16%,报10909.41点。红筹指数涨0.62%,报4454.56点。

沪港通资金流向方面,沪股通净流入44.95亿,港股通(沪)净流入3.74亿;

深港通资金流向方面,深股通净流入20.36亿,港股通(深)净流入4.8亿。

北向资金全天净流入65.31亿,为连续四日净流入,创近一个月最大净流入额。

热点板块:

苹果概念股上涨。舜宇光学涨2.85%领涨蓝筹;瑞声科技涨1.04%;丘钛科技涨5.34%。

石油股上涨。中国石油化工股份涨1.95%;中国海洋石油涨1.86%;中国石油股份涨1.18%。

内险股上涨。中国人民保险集团涨4.02%;中国平安(95.45, 1.35, 1.44%)涨1.43%;中国人寿(20.75, 0.25, 1.22%)涨1.22%。

友邦保险涨2.73%,报88.5港元,创历史新高。汇丰证券发表报告,上调友邦保险目标价1%或1港元,至95港元,维持投资评级为买入。报告预期,友邦将于8月23日公布的2019年中期业绩,新业务价值上升16%,主要来自香港、内地及泰国,其中香港占新业务35%。报告估计友邦税后营运溢利增长10%;并预期友邦派息增加14%。并且港交所权益资料显示,友邦保险获美国资本集团(The Capital Group Companies,Inc.)于7月15日以每股平均价85.4354港元增持399.28万股,涉资约3.41亿港元。增持后,美国资本集团的最新持股数目为1,091,477,137股,持股比例由8.99%升至9.03%。

中烟香港涨14.03%,报19.18港元。国泰君安曾于7月17日发布对中烟香港的研报,摘要如下:首次覆盖给予“增持”评级,目标价21.51元。公司作为中烟旗下唯一的国际业务平台,拥有烟草类产品进出口的独家经营权,在所从事业务领域没有任何竞争对手,充分受益于中烟整合海外资源及大力推广新型烟草制品的趋势。考虑到标的具备高度稀缺性、独家经营地位带来高议价能力、HNB新型烟草制品放量可期。

 

中国A股

北京时间7月19日,早盘三大股指高开高走。开盘后,燃料电池概念领涨两市,随后黄金、券商板块先后拉升,中船系、环保股随后异动,带动指数迅速走强,三大指数涨幅均超1%。总体上,市场人气火热,资金做多意愿强烈,两市仅三百余家个股下跌。临近上午收盘,三大指数冲高之后开始小幅回落,随后开始趋于平稳,成交量开始有所放缓。板块方面,市场并没有明显的热点主线,地产、券商等权重板块表现较强势,航运、深圳本地股异动拉升,其他板块表现平平,赚钱效应总体表现一般,资金情绪稍显回落。午后,两市指数午后小幅回落,随后维持高位震荡。盘面上,两市个股涨多跌少,资金情绪较早盘稍显回落。尾盘,成交有所回暖,三大股指小幅回升。

截止收盘,沪指报2924.20点,涨0.79%,深成指报9228.55点,涨0.81%。

从盘面上看,科创板对标、券商、租售同权居板块涨幅榜前列,光刻胶、种植业、乡村振兴板块跌幅榜前列。

热点板块:

燃料电池走强,金鸿控股、雪人股份、雄韬股份、汉钟精机、全柴动力等多股纷纷大涨。

消息面上工信部正联合其他部委,酝酿研究针对燃料电池的新补贴政策。据了解,相关补贴思路并不像之前那样补贴到整车厂,而是考虑补贴生产核心部件的厂家,尤其是拥有核心技术的企业将获得更有力度的政策支持。氢能属于政策主导型行业,政策对于产业发展起着重要的指引作用。

黄金持续走强,银泰资源、恒邦股份、山东黄金、湖南黄金、中金黄金、老凤祥、赤峰黄金等个股涨幅居前。

消息面上现货黄金7月18日继续大幅收涨,美市盘中最高上探至1448.00美元/盎司,金价在触及日内低位后V型反弹,重拾升势,盘中直线拉升,向上逼近1450关口。白银继续强势上涨,但涨势已有所减弱,最高触及16.34美元/盎司,已运行在16.30美元关口上方,处于4个月的高位。

科创板对标拉涨,诺德股份、长川科技、上海新阳、和佳股份、星云股份、世纪瑞尔、西部材料、三超新材、久之洋等个股纷纷拉升走高。

消息面上科创板首批25只新股的询价和发行工作已经完成,7月22日即将批量上市。据统计,上百家基金公司出动,积极参与科创板网下打新。参与科创板初步询价的产品累计2754只,基金公司、私募基金、保险公司、证券公司的配售对象数量排名靠前,其中基金公司占比高达70%。

 
如果有想了解更多全球股市资讯,请关注微信公众共 “辉立资本新加坡” (SGPSPL)

同时提供在线免费开设股票账户,一个账户轻松交易美股,港股,新加坡股
 

来源:东方财富网,新浪财经,同花顺,21世纪经济报道,彭博,华尔街见闻,辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com